Journal Report

EXPERT REVIEW OF CLINICAL PHARMACOLOGY

Download PDF
Journal Information
Journal Title
EXPERT REVIEW OF CLINICAL PHARMACOLOGY
Publisher
TAYLOR & FRANCIS LTD
ISSN
1751-2433
E-ISSN
1751-2441
Database
Clarivate
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Modern antidiabetic therapy in older adults with type 2 diabetes: evidence, best practice and a clinical pharmacist’s framework
Boštjan Martinc, Mišo Šabovič, Miodrag Janić et al.
2026-10-22
DOI: 10.1080/17512433.2026.2754390
Efficacy of minocycline-containing bismuth quadruple therapy for <i>Helicobacter pylori</i> infection: a single-center retrospective study
Xiaomin Wang, Liyan Dong, Guo Lin et al.
2026-10-21 Pages 1-9
DOI: 10.1080/17512433.2026.2749579
Therapeutic utility of clinical &amp; laboratory markers in chronic spontaneous urticaria – a narrative review
Kabir Sardana, Mohammad Adil, Aishwarya Muddebihal
2026-10-21
DOI: 10.1080/17512433.2026.2753442
Present and future of ulta-low- and low-dose triple combination therapy in hypertension: a clinical practice perspective
Moo-Yong Rhee, Jae-Sik Jang, Ki-Chul Sung et al.
2026-10-17 Pages 1-12
DOI: 10.1080/17512433.2026.2750908
Pentosan polysulfate sodium and retinal safety: reconciling conflicting evidence and defining a pragmatic clinical pharmacology framework
Shwetambari Ingawale, Hira Bakhtiar Khan, Mehwash Nadeem
2026-10-12 Pages 1-13
DOI: 10.1080/17512433.2026.2747637
Emerging pharmacological therapies for bronchiectasis
Meghan Marmor, Mark Metersky
2026-10-9 Pages 1-15
DOI: 10.1080/17512433.2026.2744253
Limitations of current neuroprotective therapies in dementia with Lewy bodies
Deirdre M. O’shea, Shanell Disla, Alyssa E. Gosling et al.
2026-10-8 Pages 1-16
DOI: 10.1080/17512433.2026.2742316
Disitamab vedotin in urothelial carcinoma patients: a clinical trial perspective from ARON working group
Concetta Calabrò, Francesco Ciccimarra, Anna Milella et al.
2026-10-7 Pages 1-11
DOI: 10.1080/17512433.2026.2744573
Off-label drug use in children: prevalence, risks, and regulation
Antje Neubert, Sonja Eberl
2026-10-3 Vol. 19 Issue 10 Pages 921-935
DOI: 10.1080/17512433.2026.2742318
Brensocatib in non-cystic fibrosis bronchiectasis: neutrophil serine protease modulation, clinical evidence, and therapeutic positioning
Muhammad Saeed Akhtar
2026-10-1 Vol. 19 Issue 10 Pages 891-901
DOI: 10.1080/17512433.2026.2739561
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: October 26, 2026 02:21